ArticlePharmaceutics2023

Retrospectives on Three Decades of Safe Clinical Experience with Allogeneic Dermal Progenitor Fibroblasts: High Versatility in Topical Cytotherapeutic Care.

Alexis Laurent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.